期刊文献+

肿瘤恶液质患者的营养治疗专家共识

Expert consensus on nutritional therapy for cancer cachexia
下载PDF
导出
摘要 恶性肿瘤的恶液质发病率高,约20%恶性肿瘤患者死于恶液质。持续性的骨骼肌消耗是恶液质的核心表现,使得患者生活质量严重下降,增加并发症的发生率和病死率。对肿瘤恶液质患者需明确诊断,并进行分期及分级,有益于患者的抗肿瘤治疗和营养治疗。肿瘤恶液质患者表现为低摄入量以及代谢异常,均会导致蛋白及能量负平衡,需要增加能量及营养素摄入以纠正能量及蛋白质的负平衡。密切的营养随访、营养咨询和对患者的营养教育是预防及治疗肿瘤恶液质的重要措施,仅仅是对食物的不同选择,以及对食物摄入量的认识,就能使患者摄入更多的能量及营养素,从而可能有助于改善患者营养状况。 The incidence rate of cachexia in malignant tumors is high,and about 20%of patients with malignant tumors die of cachexia.Persistent skeletal muscle depletion is a core manifestation of cachexia,leading to a serious decline in the quality of life of patients,an increase in the incidence of complications and mortality.Clear diagnosis,staging,and grading are necessary for patients with malignant tumors,which is beneficial for their anti-tumor and nutritional treatments.Patients with malignant tumors exhibit low intake and metabolic abnormalities,both of which can lead to a negative balance of protein and energy.It is necessary to increase energy and nutrient intake to correct the negative balance of energy and protein.Close nutritional follow-up,nutritional counseling,and patient nutrition education are important measures for preventing and treating tumor cachexia.Simply choosing different foods and understanding their intake can help patients consume more energy and nutrients,which may help improve their nutritional status.
作者 中国抗癌协会肿瘤营养专业委员会 中华医学会肠外肠内营养学分会 崔久嵬 石汉平 Chinese Society of Nutritional Oncology;Chinese Society for Parenteral and Enteral Nutrition
出处 《肿瘤代谢与营养电子杂志》 2024年第4期485-492,共8页 Electronic Journal of Metabolism and Nutrition of Cancer
基金 国家重点研发计划项目(2022YFC2009600,2022YFC2009601)。
关键词 肿瘤恶液质 营养治疗 共识 Ω-3多不饱和脂肪酸 支链氨基酸 L-谷氨酰胺 L-左旋肉碱 β-羟基-β-甲基丁酸盐 Tumor cachexia Nutritional therapy Consensus Omega-3 polyunsaturated fatty acids Branched chain amino acids L-glutamine L-carmitine β-hydroxy-β-methylbutyrate
  • 相关文献

参考文献2

  • 1李增宁,陈伟,齐玉梅,胡雯,杨道科,沈卫,葛声,周春凌,杨雪锋,张片红,赖建强,焦广宇,胡怀东,高淑清,申林,张勇胜,胡小翠,周莉,周岚,赵长海,贾润平,冯颖,吴静,辛宝,刘晓军,李莉,施万英,朱宏,杨勤兵,郑锦锋,韩磊,夏羽菡,刘庆春,方玉,胡环宇,骆彬,李薇,王昆华,陈子华,林源,缪明永,许红霞,崔久嵬,路潜,郭增清,陈媛媛,李涛,刘波,李苏宜,李勇,江波,张彩霞,庄则豪,吕全军,巴一,陈公琰,孙明晓,吴健雄,秦宝丽,汪志明,马东,杨柳青,王晓琳,曲芊诺,牛犁天,贾云鹤,曹伟新,石汉平.肿瘤患者特殊医学用途配方食品应用专家共识[J].肿瘤代谢与营养电子杂志,2016,3(2):95-99. 被引量:33
  • 2Tomoyoshi Aoyagi,Krista P Terracina,Ali Raza,Hisahiro Matsubara,Kazuaki Takabe.Cancer cachexia,mechanism and treatment[J].World Journal of Gastrointestinal Oncology,2015,7(4):17-29. 被引量:22

二级参考文献225

  • 1Tisdale MJ. Mechanisms of cancer cachexia. Physiol Rev 2009;89: 381-410 [PMID: 19342610 DOI: 10.1152/physrev.00016.2008].
  • 2Fearon K, Arends J, Baracos V. Understanding the mechanismsand treatment options in cancer cachexia. Nat Rev Clin Oncol 2013;10: 90-99 [PMID: 23207794 DOI: 10.1038/nrclinonc.2012.209].
  • 3Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, FainsingerRL, Jatoi A, Loprinzi C, MacDonald N, Mantovani G, Davis M,Muscaritoli M, Ottery F, Radbruch L, Ravasco P, Walsh D, WilcockA, Kaasa S, Baracos VE. Definition and classification of cancer cachexia:an international consensus. Lancet Oncol 2011; 12: 489-495[PMID: 21296615 DOI: 10.1016/S1470-2045(10)70218-7].
  • 4Evans WJ, Morley JE, Argilés J, Bales C, Baracos V, GuttridgeD, Jatoi A, Kalantar-Zadeh K, Lochs H, Mantovani G, Marks D,Mitch WE, Muscaritoli M, Najand A, Ponikowski P, Rossi Fanelli F,Schambelan M, Schols A, Schuster M, Thomas D, Wolfe R, AnkerSD. Cachexia: a new definition. Clin Nutr 2008; 27: 793-799 [PMID:18718696 DOI: 10.1016/j.clnu.2008.06.013].
  • 5Tisdale MJ. Cachexia in cancer patients. Nat Rev Cancer 2002; 2:862-871 [PMID: 12415256 DOI: 10.1038/nrc927].
  • 6Congleton J. The pulmonary cachexia syndrome: aspects of energybalance. Proc Nutr Soc 1999; 58: 321-328 [PMID: 10466173].
  • 7von Haehling S, Lainscak M, Springer J, Anker SD. Cardiac cachexia:a systematic overview. Pharmacol Ther 2009; 121: 227-252#[PMID: 19061914 DOI: 10.1016/j.pharmthera.2008.09.009].
  • 8Giordano A, Calvani M, Petillo O, Carteni' M, Melone MR, PelusoG. Skeletal muscle metabolism in physiology and in cancerdisease. J Cell Biochem 2003; 90: 170-186 [PMID: 12938166 DOI:10.1002/jcb.10601].
  • 9Dewys WD, Begg C, Lavin PT, Band PR, Bennett JM, BertinoJR, Cohen MH, Douglass HO, Engstrom PF, Ezdinli EZ, HortonJ, Johnson GJ, Moertel CG, Oken MM, Perlia C, Rosenbaum C,Silverstein MN, Skeel RT, Sponzo RW, Tormey DC. Prognostic effectof weight loss prior to chemotherapy in cancer patients. EasternCooperative Oncology Group. Am J Med 1980; 69: 491-497 [PMID:7424938].
  • 10Deans C, Wigmore SJ. Systemic inflammation, cachexia andprognosis in patients with cancer. Curr Opin Clin Nutr Metab Care2005; 8: 265-269 [PMID: 15809528].

共引文献53

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部